Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Apr;50(4):1268-75.
doi: 10.1128/AAC.50.4.1268-1275.2006.

Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis

Affiliations

Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis

John J Curtin et al. Antimicrob Agents Chemother. 2006 Apr.

Abstract

Use of indwelling catheters is often compromised as a result of biofilm formation. This study investigated if hydrogel-coated catheters pretreated with a coagulase-negative bacteriophage would reduce Staphylococcus epidermidis biofilm formation. Biofilms were developed on hydrogel-coated silicone catheters installed in a modified drip flow reactor. Catheter segments were pretreated with the lytic S. epidermidis bacteriophage 456 by exposing the catheter lumen to a 10-log-PFU/ml culture of the bacteriophage for 1 h at 37 degrees C prior to biofilm formation. The untreated mean biofilm cell count was 7.01+/-0.47 log CFU/cm2 of catheter. Bacteriophage treatment with and without supplemental divalent cations resulted in log-CFU/cm2 reductions of 4.47 (P<0.0001) and 2.34 (P=0.001), respectively. Divalent cation supplementation without bacteriophage treatment provided a 0.67-log-CFU/cm2 reduction (P=0.053). Treatment of hydrogel-coated silicone catheters with an S. epidermidis bacteriophage in an in vitro model system significantly reduced viable biofilm formation by S. epidermidis over a 24-h exposure period, suggesting the potential of bacteriophage for mitigating biofilm formation on indwelling catheters and reducing the incidence of catheter-related infections.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Modified drip flow reactor, showing catheter segments in each of the four chambers.
FIG. 2.
FIG. 2.
Model system used for evaluating the effect of phage treatment on biofilm formation. The various parts are labeled as follows: 1, magnetic stirrer; 2, batch culture; 3, sterile medium reservoir; 4, peristaltic pump; 5, mDFR; 6, waste reservoir.
FIG. 3.
FIG. 3.
Effect of phage pretreatment of catheter surface on biofilm formation. ♦, mean log CFU/cm2 of viable S. epidermidis 414 recovered from hydrogel-coated catheters; ▪, mean log CFU/cm2 of viable S. epidermidis 414 recovered from hydrogel-coated catheters pretreated with phage 456; ○, mean log CFU/cm2 of viable S. epidermidis 414 recovered from hydrogel-coated catheters pretreated with phage 456 (MHB supplemented with divalent cations). Error bars represent ±standard deviation (n = 3).
FIG. 4.
FIG. 4.
Effect of heat-inactivated phage and divalent cations on biofilm formation on catheter surface. ♦, mean log CFU/cm2 of viable S. epidermidis 414 recovered from hydrogel-coated catheters; ▪, mean log CFU/cm2 of viable S. epidermidis 414 recovered from hydrogel-coated catheters (MHB supplemented with divalent cations); ○, mean log CFU/cm2 of viable S. epidermidis 414 recovered from hydrogel-coated catheters pretreated with heat-inactivated phage 456; □, mean log CFU/cm2 of viable S. epidermidis 414 recovered from hydrogel-coated catheters pretreated with heat-inactivated phage 456 (MHB supplemented with divalent cations). Error bars represent ±standard deviation (n = 3).
FIG. 5.
FIG. 5.
Viable phage recovered from catheter lumens. ▪, mean log PFU/ml of viable phage 456 recovered from phage- pretreated hydrogel-coated catheters during biofilm formation; ○, mean log PFU/ml of viable phage 456 recovered from phage-pretreated hydrogel-coated catheters during biofilm formation (MHB supplemented with divalent cations); ▴, mean log PFU/ml of viable phage 456 recovered from phage-pretreated and subsequently serum-coated, hydrogel-coated catheters during biofilm formation (MHB supplemented with divalent cations). Error bars represent ±standard deviation (n = 3).
FIG. 6.
FIG. 6.
(A) Scanning electron micrograph of the surface of a section of a Lubri-sil hydrogel-coated all-silicone Foley catheter after biofilm formation by S. epidermidis 414 for 24 h (×3,000 magnification). Attached cells are clearly visible in large quantities on the surface. (B) Surface of a section of a Lubri-sil hydrogel-coated all-silicone Foley catheter pretreated with phage 456 after biofilm formation by S. epidermidis 414 for 24 h (×3,000 magnification) with divalent cation-supplemented MHB. No biofilm matrix or clusters of attached cells are visible (images represent typical fields of view).

Similar articles

Cited by

References

    1. Adams, M. 1959. Bacteriophages. Interscience Publishers, London, United Kingdom.
    1. Barrow, P., M. Lovell, and A. Berchieri, Jr. 1998. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin. Diagn. Lab. Immunol. 5:294-298. - PMC - PubMed
    1. Benoit, J. L., G. Carandang, M. Sitrin, and P. M. Arnow. 1995. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin. Infect. Dis. 21:1286-1288. - PubMed
    1. Biswas, B., S. Adhya, P. Washart, B. Paul, A. N. Trostel, B. Powell, R. Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210. - PMC - PubMed
    1. Capdevila, J. A., J. Gavalda, and A. Pahissa. 1996. Antibiotic-lock technique: usefulness and controversies. Antimicrobics Infect. Dis. Newsl. 15:9-13.

Publication types

MeSH terms